SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ: BSDM) announces the installation of the advanced BSD-2000/3D Hyperthermia System at the Department of Radiation Oncology of Kantonsspital Aarau (KSA), Aarau, Switzerland. The BSD-2000/3D at KSA will be used to deliver targeted hyperthermia to deep pelvic and abdominal tumors, using focused phased array RF energy, in order to enhance treatment with radiotherapy and chemotherapy. The purchase of the BSD-2000/3D adds sophisticated technology to KSA’s hyperthermia cancer therapy program. KSA had already joined BSD’s family of customers with the purchase of a BSD-500 superficial hyperthermia system.
